AOXING PHARMACEUTICAL COMPANY, INC. Financial Statements (2024 and earlier)

Company Profile

Business Address 1098 FOSTER CITY BLVD.
FOSTER CITY, CA 94404
State of Incorp. FL
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2017
MRQ
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 6,9125,3722,3304,008
Cash and cash equivalents 6,9125,3722,3304,008
Receivables 11,2005,8543,8912,843
Inventory, net of allowances, customer advances and progress billings 2,8423,2402,1952,622
Inventory 2,8423,2402,1952,622
Intangible current assets 1,878485
Other undisclosed current assets 4,0346,1462,5052,420
Total current assets: 26,86721,09610,92111,892
Noncurrent Assets
Property, plant and equipment 25,60428,65226,41926,942
Long-term investments and receivables 496189292
Long-term investments 496189292
Intangible assets, net (including goodwill) 1,878485546
Intangible assets, net (excluding goodwill) 1,878485546 
Other undisclosed noncurrent assets 1,8792,712 607
Total noncurrent assets: 29,36531,94527,15427,841
TOTAL ASSETS: 56,23253,04138,07539,733
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 9,6347,1764,4354,409
Interest and dividends payable 2,6032,0731,295 
Taxes payable 2,6201,282418255
Employee-related liabilities 1,2121,664864 
Accounts payable 2,7103,6253,8833,412
Accrued liabilities 2771,053233 
Other undisclosed accounts payable and accrued liabilities 213(2,521)(2,259)741
Debt 25,45928,80121,56511,780
Due to related parties 1361,0842,102
Customer advances and deposits 414291733
Other undisclosed current liabilities 2,2964,9666,3983,412
Total current liabilities: 37,81641,24034,21521,704
Noncurrent Liabilities
Long-term debt and lease obligation  1,3611,35511,520
Long-term debt, excluding current maturities  1,3611,35511,520
Liabilities, other than long-term debt  86,1471,561
Due to related parties  86,1471,561
Other undisclosed noncurrent liabilities 340369367365
Total noncurrent liabilities: 3401,7387,86913,446
Total liabilities: 38,15642,97842,08335,149
Equity
Equity, attributable to parent 19,13611,238(2,505)5,670
Common stock 76705050
Additional paid in capital 73,63066,45758,31558,297
Accumulated other comprehensive income 1,7243,0662,9792,957
Accumulated deficit (56,294)(58,355)(63,850)(55,634)
Equity, attributable to noncontrolling interest (1,060)(1,175)(1,504)(1,086)
Total equity: 18,07610,063(4,009)4,584
TOTAL LIABILITIES AND EQUITY: 56,23253,04138,07539,733

Income Statement (P&L) ($ in thousands)

3/31/2017
TTM
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues
(Revenue, Net)
 32,33025,48112,73910,830
Cost of revenue
(Cost of Goods and Services Sold)
 (7,776)(5,689)(6,926)(4,562)
Gross profit: 24,55419,7925,8146,268
Operating expenses (18,326)(11,097)(9,149)(20,489)
Other operating income (expense), net
(Other Expenses)
 3,3425,5825,300(3,069)
Other undisclosed operating income (loss) (3,342)(5,582)(5,300)3,069
Operating income (loss): 6,2288,696(3,335)(14,221)
Income (loss) from continuing operations before equity method investments, income taxes: 6,2288,696(3,335)(14,221)
Loss from equity method investments (88)(93)(105)(115)
Other undisclosed loss from continuing operations before income taxes (3,255)(5,488)(5,195)(2,954)
Income (loss) from continuing operations before income taxes: 2,8863,114(8,634)(17,291)
Income tax expense (benefit) (642)2,704(2,416) 
Income (loss) from continuing operations: 2,2445,818(11,051)(17,291)
Income (loss) before gain (loss) on sale of properties: 2,2445,818(11,051)(17,291)
Other undisclosed net income (loss)  (324)2,835 
Net income (loss): 2,2445,495(8,216)(17,291)
Net income (loss) attributable to noncontrolling interest (182)(324)419486
Other undisclosed net income (loss) attributable to parent  648(837) 
Net income (loss) available to common stockholders, diluted: 2,0615,818(8,634)(16,804)

Comprehensive Income ($ in thousands)

3/31/2017
TTM
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net income (loss): 2,2445,495(8,216)(17,291)
Other comprehensive income (loss) 1,409(91)(24) 
Other undisclosed comprehensive income (loss) (2,934)18352801
Comprehensive income (loss): 7195,586(8,188)(16,490)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest (115)(328)417(471)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 182324(419)455
Comprehensive income (loss), net of tax, attributable to parent: 7865,582(8,189)(16,506)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: